S&P 500 Roars Higher on Omicron Optimism as Traders Reassess Pandemic Risks

S&P 500 rises for a second straight day as traders are comforted by preliminary datasuggesting that Omicron causes only mild disease and remains sensitive to vaccines’ neutralizing antibodies